Merck Biopharma Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 10,001
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 3
  • Investments
  • 9

Merck Biopharma General Information

Description

Operator of bio pharmaceutical company. The company specializes in the manufacturing of cancer and cardiovascular drugs.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • Frankfurter Straße 250
  • 64293 Darmstadt
  • Germany
+49 06151 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Merck Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merck Biopharma‘s full profile, request access.

Request a free trial

Merck Biopharma Executive Team (18)

Name Title Board Seat Contact Info
Philipp Harbach Head of In Silico Research
Liz Henderson Regional Vice President, Asia Pacific
Stephan Oschmann Ph.D Chairman of the Executive Board & Chief Executive Officer
Marcus Kuhnert Ph.D Chief Financial Officer & Member of the Executive Board
You’re viewing 4 of 18 executive team members. Get the full list »

Merck Biopharma Board Members (3)

Name Representing Role Since
000000 0000000 00.0 Self Chief Financial Officer & Member of the Executive Board 000 0000
0000000 00000000 00.0 Self Chairman of the Executive Board & Chief Executive Officer 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Merck Biopharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Merck Biopharma Investments & Acquisitions (9)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 0000000 000000 01-Jan-2018 00000 Business/Productivity Software 0000000 0000000
000000000 00000000 15-Dec-2016 00000 00000 Drug Discovery
00000 000000 22-Sep-2016 00000 0000 Other Containers and Packaging
00000.00 01-Jan-2015 00000 Social Content
Neviah Genomics 25-Jun-2012 Joint Venture Biotechnology
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Merck Biopharma Exits (6)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000 22-Sep-2016 00000 0000 Completed
  • 00000 000000000
000000 00000000 25-Jun-2012 00000 0000000 Completed
  • 3 buyers
00000 000000 21-Sep-2006 000000000000000000 000.00 Completed
  • 00000 000000000
00000 000000 & 000 01-Jan-2005 000000000 00000 00 00000 Completed
  • 00000 000000000
Merck Serono & BioMarin Pharmaceutical (Kuvan Rights) Corporate Asset Purchase Completed
You’re viewing 5 of 6 exits. Get the full list »